Profound Medical (PROF) Short Interest Ratio & Short Volume $4.27 -0.01 (-0.23%) As of 05/13/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Profound Medical Short Interest DataProfound Medical (PROF) has a short interest of 493,600 shares, representing 1.67% of the float (the number of shares available for trading by the public). This marks a 0.39% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.0, indicating that it would take 6.0 days of the average trading volume of 61,630 shares to cover all short positions.Current Short Interest493,600 sharesPrevious Short Interest491,700 sharesChange Vs. Previous Month+0.39%Dollar Volume Sold Short$2.46 millionShort Interest Ratio6.0 Days to CoverLast Record DateApril 30, 2025Outstanding Shares30,053,000 sharesShort Percent of Float1.67%Today's Trading Volume86,029 sharesAverage Trading Volume61,630 sharesToday's Volume Vs. Average140% Short Selling Profound Medical? Sign up to receive the latest short interest report for Profound Medical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPROF Short Interest Over TimePROF Days to Cover Over TimePROF Percentage of Float Shorted Over Time Profound Medical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025493,600 shares $2.46 million +0.4%1.7%6 $4.99 4/15/2025491,700 shares $2.37 million -0.3%1.7%6.1 $4.81 3/31/2025493,400 shares $2.87 million +1.1%1.7%6.1 $5.82 3/15/2025488,100 shares $3.39 million +2.8%1.6%6.9 $6.95 2/28/2025474,700 shares $3.29 million +23.9%1.6%5.3 $6.93 2/15/2025383,200 shares $2.57 million +11.0%1.3%4.3 $6.70 1/31/2025345,200 shares $2.23 million -9.7%N/A4.5 $6.45 1/15/2025382,200 shares $2.82 million +3.3%N/A5.3 $7.38 12/31/2024369,900 shares $2.78 million -2.2%N/A5.6 $7.51 12/15/2024378,300 shares $2.80 million +11.9%N/A5.6 $7.40 Get the Latest News and Ratings for PROF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024338,200 shares $2.75 million -2.8%N/A5.1 $8.12 11/15/2024348,000 shares $2.79 million +2.2%N/A7.2 $8.01 10/31/2024340,500 shares $2.48 million +1.5%N/A6.7 $7.27 10/15/2024335,400 shares $2.54 million -1.5%N/A7.1 $7.58 9/30/2024340,600 shares $2.71 million +7.0%N/A6.5 $7.96 9/15/2024318,300 shares $2.46 million -10.1%N/A7.1 $7.72 8/31/2024354,200 shares $3.24 million +0.1%N/A9.9 $9.15 8/15/2024353,900 shares $3.35 million -3.3%N/A10 $9.47 7/31/2024365,800 shares $3.87 million +7.4%N/A11.1 $10.58 7/15/2024340,600 shares $3.12 million -1.7%N/A11.4 $9.15 6/30/2024346,400 shares $2.91 million +8.7%N/A14.2 $8.39 6/15/2024318,600 shares $2.63 million +5.1%N/A12.4 $8.27 5/31/2024303,200 shares $2.23 million +3.7%N/A11.2 $7.37 5/15/2024292,500 shares $2.50 million -5.7%N/A9 $8.54 4/30/2024310,200 shares $2.31 million -1.1%N/A9.3 $7.44 4/15/2024313,700 shares $2.48 million -2.9%N/A8 $7.90 3/31/2024323,200 shares $2.76 million +0.8%N/A7.6 $8.53 3/15/2024320,700 shares $2.73 million -2.3%N/A5.1 $8.52 2/29/2024328,100 shares $3.02 million -4.6%1.7%5.3 $9.20 2/15/2024343,900 shares $2.92 million -1.8%1.8%6.2 $8.49 1/31/2024350,100 shares $3.12 million +6.4%1.8%6.7 $8.92 1/15/2024329,100 shares $2.50 million -23.6%1.7%7.5 $7.60 12/31/2023430,600 shares $3.66 million +37.1%N/A10.8 $8.49 12/15/2023314,200 shares $2.99 million +3.2%N/A16.1 $9.52 11/30/2023304,600 shares $3.30 million +4.2%N/A18.8 $10.85 11/15/2023292,400 shares $2.76 million +11.2%N/A18.3 $9.44 10/31/2023262,900 shares $2.18 million +0.2%N/A17.6 $8.31 10/15/2023262,400 shares $2.44 million +5.6%N/A17.7 $9.30 9/30/2023248,400 shares $2.53 million +33.8%N/A15.2 $10.20 9/15/2023185,600 shares $1.48 million +6.8%N/A10.7 $8.00The world’s first multi- trillion-dollar robotics industry … (Ad)Robots are standing on the edge of history. No one would know this better than Nvidia's Jensen Huang. In Las Vegas, the CEO of the world's most valuable company did more than just talk. He laid out their vision for building the world's first trillion-dollar robot. Kickstarting a multi-trillion-dollar robotics industry.I'll tell you more about the $7 company Huang and Nvidia joined forces with to make it happen. 8/31/2023173,800 shares $1.55 million -13.3%N/A8.2 $8.89 8/15/2023200,400 shares $1.94 million +2.3%N/A7.7 $9.67 7/31/2023195,900 shares $2.24 million -14.5%1.0%6.9 $11.45 7/15/2023229,000 shares $3.02 million -10.8%1.2%7.6 $13.20 6/30/2023256,600 shares $3.34 million -27.1%1.3%8.4 $13.01 6/15/2023351,900 shares $4.79 million -10.3%1.8%11.7 $13.62 5/31/2023392,300 shares $4.73 million -5.1%2.0%15 $12.05 5/15/2023413,500 shares $5.24 million -1.1%2.1%16.3 $12.67 4/30/2023418,200 shares $4.85 million -4.0%2.1%17.4 $11.60 4/15/2023435,700 shares $4.40 million -0.8%2.2%16.9 $10.10 3/31/2023439,100 shares $4.08 million -1.4%2.2%15.6 $9.29 3/15/2023445,100 shares $4.65 million -3.6%2.3%11.2 $10.45 2/28/2023461,900 shares $6.07 million +1.4%2.4%7.5 $13.15 2/15/2023455,500 shares $5.56 million -3.4%2.3%7.1 $12.21 1/31/2023471,700 shares $5.83 million +4.8%2.4%6.9 $12.35 1/15/2023450,100 shares $5.55 million +3.0%2.3%5.9 $12.34 12/30/2022437,000 shares $4.76 million +63.6%2.3%5 $10.89 12/15/2022267,200 shares $2.36 million +0.4%1.4%3 $8.82 11/30/2022266,200 shares $1.27 million -4.3%1.4%3.2 $4.76 11/15/2022278,200 shares $1.43 million -3.1%1.4%3.7 $5.13 10/31/2022287,100 shares $1.19 million -35.0%1.5%4.1 $4.14 10/15/2022441,500 shares $1.58 million +3.6%2.3%7.3 $3.57 9/30/2022426,200 shares $1.72 million +12.0%2.3%8.9 $4.04 9/15/2022380,500 shares $1.98 million +0.2%2.0%10.4 $5.20 8/31/2022379,900 shares $2.64 million -2.3%2.0%19.8 $6.95 8/15/2022388,700 shares $2.80 million -10.6%2.1%17.6 $7.21 7/31/2022434,800 shares $3.74 million -4.7%2.3%15 $8.61 7/15/2022456,000 shares $3.42 million -4.2%2.4%15.1 $7.51 6/30/2022475,800 shares $3.47 million -17.2%2.5%14.4 $7.29 6/15/2022574,700 shares $4.52 million +4.5%3.1%15.7 $7.87 5/31/2022550,000 shares $5.10 million +9.7%2.9%12.7 $9.27 5/15/2022501,500 shares $3.49 million -1.9%2.7%9.2 $6.95 4/30/2022511,400 shares $3.73 million +3.4%2.7%9.8 $7.30 4/15/2022494,400 shares $4.15 million +7.3%2.5%8.5 $8.39 3/31/2022460,700 shares $4.15 million +1.4%2.3%7.7 $9.00 3/15/2022454,300 shares $3.80 million -35.5%2.3%6.7 $8.36 2/28/2022704,500 shares $7.53 million -29.4%3.6%10.1 $10.69 2/15/2022997,500 shares $9.71 million +21.5%5.1%14.8 $9.73 1/31/2022820,800 shares $8.13 million +11.1%4.2%12.2 $9.90 1/15/2022738,500 shares $7.41 million +15.5%3.8%9.2 $10.04 12/31/2021639,600 shares $7.18 million +2.8%3.3%8.3 $11.23 12/15/2021622,000 shares $6.61 million +5.6%3.2%7.8 $10.62 11/30/2021589,200 shares $6.45 million +11.3%3.0%7.8 $10.95 11/15/2021529,400 shares $6.38 million -14.0%2.7%7.5 $12.06 10/29/2021615,200 shares $8.31 million +19.0%3.1%9 $13.51 10/15/2021517,100 shares $7.76 million +7.5%2.7%6.8 $15.01 9/30/2021480,900 shares $7.04 million -3.9%2.5%6.6 $14.64 9/15/2021500,300 shares $6.91 million +0.3%2.6%7.2 $13.81 8/31/2021499,000 shares $7.42 million -2.0%2.6%7.6 $14.86 8/13/2021509,300 shares $7.77 million -3.2%2.6%8.1 $15.25Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 7/30/2021526,200 shares $7.68 million -1.0%2.7%8.1 $14.60 7/15/2021531,400 shares $8.61 million +3.4%3.0%11.2 $16.20 6/30/2021513,900 shares $8.41 million -5.8%2.9%11.2 $16.36 6/15/2021545,600 shares $10.34 million -7.2%3.0%11 $18.96 5/28/2021587,900 shares $10.39 million +7.5%3.3%10.7 $17.67 5/14/2021547,100 shares $9.20 million +24.1%3.0%8.2 $16.82 4/30/2021440,900 shares $8.04 million +2.2%2.5%6.2 $18.24 4/15/2021431,500 shares $8.62 million +1.2%2.4%5.2 $19.98 3/31/2021426,400 shares $8.22 million -4.7%2.4%5 $19.27 3/15/2021447,600 shares $10.38 million +36.8%2.5%4.9 $23.19 2/26/2021327,100 shares $7.06 million +1.3%1.8%3.6 $21.57 2/12/2021322,900 shares $8.58 million -4.0%1.8%3.4 $26.57 1/29/2021336,400 shares $9.07 million -0.8%2.0%3.6 $26.97 1/15/2021339,100 shares $8.29 million +7.8%2.0%4 $24.45 12/31/2020314,600 shares $6.53 million +0.4%1.9%3.9 $20.77 12/15/2020313,500 shares $5.61 million +6.2%1.9%3.9 $17.90 11/30/2020295,300 shares $5.61 million +2.1%1.8%3.5 $19.00 11/15/2020289,300 shares $5.38 million -28.8%1.8%3.9 $18.61 10/30/2020406,500 shares $7.14 million +2.8%2.5%5.5 $17.56 10/15/2020395,300 shares $6.82 million +2.4%2.4%5 $17.26 PROF Short Interest - Frequently Asked Questions What is Profound Medical's current short interest? Short interest is the volume of Profound Medical shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 493,600 shares of PROF short. 1.67% of Profound Medical's shares are currently sold short. Learn More on Profound Medical's current short interest. What is a good short interest ratio for Profound Medical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PROF shares currently have a short interest ratio of 6.0. Learn More on Profound Medical's short interest ratio. Which institutional investors are shorting Profound Medical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Profound Medical: Simplex Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Profound Medical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.67% of Profound Medical's floating shares are currently sold short. Is Profound Medical's short interest increasing or decreasing? Profound Medical saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 493,600 shares, an increase of 0.4% from the previous total of 491,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Profound Medical's short interest compare to its competitors? 1.67% of Profound Medical's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Profound Medical: SI-BONE, Inc. (3.75%), RxSight, Inc. (9.51%), Avanos Medical, Inc. (2.53%), Butterfly Network, Inc. (7.42%), OrthoPediatrics Corp. (7.05%), Treace Medical Concepts, Inc. (4.97%), Delcath Systems, Inc. (3.81%), ClearPoint Neuro, Inc. (4.13%), NeuroPace, Inc. (1.70%), Tactile Systems Technology, Inc. (9.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Strategy Incorporated ($10.45 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), Apollo Global Management, Inc. ($3.83 billion), The Kroger Co. ($2.56 billion), Hims & Hers Health, Inc. ($2.06 billion), Dell Technologies Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.90 billion), Amcor plc ($1.76 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Profound Medical stock? Short selling PROF is an investing strategy that aims to generate trading profit from Profound Medical as its price is falling. PROF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Profound Medical? A short squeeze for Profound Medical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PROF, which in turn drives the price of the stock up even further. How often is Profound Medical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PROF, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies SI-BONE Short Squeeze RxSight Short Squeeze Avanos Medical Short Squeeze Butterfly Network Short Squeeze OrthoPediatrics Short Squeeze Treace Medical Concepts Short Squeeze Delcath Systems Short Squeeze ClearPoint Neuro Short Squeeze NeuroPace Short Squeeze Tactile Systems Technology Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PROF) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersThe world’s first multi- trillion-dollar robotics industry …Robots are standing on the edge of history. No one would know this better than Nvidia's Jensen Huang. In...Weiss Ratings | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PROF Stock Free PROF Stock Alerts